Access cutting-edge obsessive-compulsive disorder (ocd) treatment through this clinical trial at a research site in Queens. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Queens location
Preparing your pre-screening questions…
Access obsessive-compulsive disorder (ocd) specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related obsessive-compulsive disorder (ocd) treatment provided free
Check if you qualify for this obsessive-compulsive disorder (ocd) clinical trial in Queens, NY
No-Cost Study Care
Local to Queens
Convenient for NY residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
There are two primary approaches to the treatment of OCD, pharmacotherapy and cognitive behavior therapy (CBT). Lack of therapeutic success with one approach leads to trials of the alternative approach or a combination of the two. A rarely used third therapy approach, appropriate for only the most severely afflicted and treatment resistant patients, is neurosurgical ablation of certain brain regions involved in mood and anxiety. The neurosurgical ablation procedures are irreversible in nature, and involve the destruction of specific volumes of brain tissue through various controlled means. Surgical procedures include cingulotomy, subcaudate tractotomy, limbic leucotomy which is a combination of the first two procedures and capsulotomy. DBS therapy is an alternative to neurosurgical procedures, specifically anterior capsulotomy, for patients with chronic, severe OCD which has proven resistant to primary pharmacological and/or behavior therapy options. Results from 26 severe, treatment-resistant OCD patients treated with DBS at four collaborating centers, three in the US, and one in Europe are summarized in great detail in pages 12-22 of the provided/attached "Reclaim Summary of Safety and Probable Benefit."
Sponsor: Northwell Health
Yes, this clinical trial (NCT02773082) has an active research site in Queens, NY that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for obsessive-compulsive disorder (ocd) treatment options in Queens, NY, this clinical trial (NCT02773082) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Queens research site is actively enrolling participants for this clinical trial. You'll receive care from experienced obsessive-compulsive disorder (ocd) specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all obsessive-compulsive disorder (ocd) clinical trials near you to find additional studies recruiting in your area.
See all ocd clinical trials recruiting in Queens — not just this study.
Browse OCD Trials in Queens →